Normopress Forte (Amlodipine, Lisinopril)

Amlodipine and Lisinopril, the active ingredients in Normopress Forte, are a calcium channel blocker and an ACE inhibitor presented as a tablet for oral use. They work together to lower elevated blood pressure in adult patients with hypertension. It is marketed throughout the European Union and is prescribed by clinicians for long‑term blood pressure management.

GNH USA supplies Normopress Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Normopress Forte, a fixed‑dose combination antihypertensive, is used to treat conditions characterized by high arterial pressure.

- Hypertension: provides effective reduction of systolic and diastolic blood pressure in adult patients. - Essential hypertension: improves blood pressure control when monotherapy is insufficient. - High blood pressure: offers a convenient once‑daily regimen to aid adherence.

The most frequently reported adverse reactions with Normopress Forte involve the cardiovascular and metabolic systems, while rare events may be severe.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Dizziness: especially on standing. - Flushing: transient warmth sensation. - Cough: dry, non‑productive. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure. - Hepatic dysfunction: elevated liver enzymes. - Renal impairment: worsening kidney function. - Hyperkalemia: elevated serum potassium levels.

Before prescribing Normopress Forte, clinicians should evaluate patient history and monitor relevant parameters. - Renal function: assess creatinine clearance before initiation and periodically. - Electrolytes: monitor potassium levels, especially if combined with potassium‑sparing agents. - Pregnancy: avoid use unless clearly needed, as safety data are limited. - Concomitant ACE inhibitors: do not combine with other ACE inhibitors or ARBs. - Hypotension risk: start at low dose in patients prone to low blood pressure. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Normopress Forte may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Aliskiren: combined use with ACE inhibitors can increase risk of renal dysfunction. - Lithium: ACE inhibition may raise lithium levels, risking toxicity. - NSAIDs: may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypotensive effect, monitor blood pressure. - Potassium supplements or potassium‑sparing diuretics: increase risk of hyperkalemia. - CYP3A4 inhibitors (e.g., clarithromycin): can raise amlodipine concentrations.